Current Report Filing (8-k)
15 12월 2022 - 11:22PM
Edgar (US Regulatory)
falseNONE0001824893Surrozen, Inc./DENONE00018248932022-12-122022-12-120001824893us-gaap:CommonStockMember2022-12-122022-12-120001824893srzn:RedeemableWarrantMember2022-12-122022-12-12
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
Date of Report (Date of earliest event reported): December 12, 2022 |
Surrozen, Inc.
(Exact name of Registrant as Specified in Its Charter)
|
|
|
|
|
Delaware |
001-39635 |
98-1556622 |
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
|
|
|
|
|
171 Oyster Point Blvd Suite 400 |
|
South San Francisco, California |
|
94080 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
|
Registrant’s Telephone Number, Including Area Code: +1 (650) 489-9000 |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
Title of each class
|
|
Trading Symbol(s) |
|
Name of each exchange on which registered
|
Common Stock, $0.0001 par value per share |
|
SRZN |
|
The Nasdaq Capital Market |
Redeemable warrants, each whole warrant exercisable for one share of Common Stock |
|
SRZNW |
|
The Nasdaq Capital Market |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events.
Repurchase of Common Stock and Warrants to Purchase Common Stock
On December 12, 2022, Surrozen, Inc. entered into a securities purchase agreement with entities affiliated with Consonance Capital Management LP, collectively the Consonance Entities. Pursuant to the agreement, on December 15, 2022, we repurchased an aggregate of 5,382,499 shares of our common stock and warrants to purchase an aggregate 1,310,496 shares of our common stock from the Consonance Entities for an aggregate purchase price of approximately $2.7 million. The shares of common stock will be returned to authorized and unissued status and the warrants will be cancelled. Following the repurchase, the Consonance Entities no longer hold any shares of Surrozen common stock or warrants to purchase Surrozen common stock.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
|
|
SURROZEN, INC. |
|
|
|
|
Date: |
December 15, 2022 |
By: |
/s/ Charles Williams |
|
|
|
Name: Charles Williams Title: Chief Financial Officer |
Consonance HFW Acquisition (AMEX:CHFW)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Consonance HFW Acquisition (AMEX:CHFW)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
Consonance HFW Acquisition Corp (아메리카 증권거래소)의 실시간 뉴스: 최근 기사 0
More Surrozen, Inc./de News Articles